help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Athan, E.
Right arrow Articles by Knowles, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Athan, E.
Right arrow Articles by Knowles, D. M.

American Journal of Pathology, Vol 138, 591-599, Copyright © 1991 by American Society for Investigative Pathology


REGULAR ARTICLES

bcl-1 rearrangement. Frequency and clinical significance among B-cell chronic lymphocytic leukemias and non-Hodgkin's lymphomas

E Athan, DR Foitl and DM Knowles
Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York 10032.

The authors investigated the structural organization of the bcl-1 locus, a putative oncogene associated with reciprocal chromosomal translocation t(11;14), by Southern blot hybridization analysis and its frequency, distribution, and prognostic significance in a panel of 156 clinically and pathologically well-defined B-cell chronic lymphocytic leukemias (CLLs) and non-Hodgkin's lymphomas (NHLs). The authors detected bcl-1 rearrangements in only 2 of 42 CLLs and 4 of 114 NHLs, specifically 3 of 29 diffuse small lymphocytic and 1 of 10 diffuse small cleaved cell and none of 5 diffuse intermediate lymphocytic, 13 follicular predominantly small cleaved, 17 follicular mixed small cleaved and large cell, 4 diffuse mixed small and large cell, 26 diffuse large cell, and 10 diffuse small noncleaved cell lymphomas. None of seven cases of Rai stage III or IV CLL or seven diffuse large cell lymphomas occurring as Richter's syndrome exhibited bcl-1 rearrangements. In conclusion, the bcl-1 locus rearranges in only about 4% of B-cell CLLs and NHLs, is predominantly rearranged in low-grade B- cell neoplasms, and does not appear to be preferentially associated with those occasional CLLs and low-grade NHLs displaying clinical aggressiveness, advanced clinical stage, or large cell transformation (Richter's syndrome). Therefore the demonstration of bcl-1 rearrangement does not appear to have clinically useful prognostic significance.


This article has been cited by other articles:


Home page
Clin. Chem.Home page
W. N. Rezuke, E. C. Abernathy, and G. J. Tsongalis
Molecular diagnosis of B- and T-cell lymphomas: fundamental principles and clinical applications
Clin. Chem., October 1, 1997; 43(10): 1814 - 1823.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. C. Amrein and D. J. Weissman
Case 43-1994- A 52-Year-Old Woman with Weakness, Diarrhea, and Diffuse Lymphadenopathy
N. Engl. J. Med., December 8, 1994; 331(23): 1576 - 1583.
[Full Text]


Home page
NEJMHome page
M. J. Cline
The Molecular Basis of Leukemia
N. Engl. J. Med., February 3, 1994; 330(5): 328 - 336.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society for Investigative Pathology.